Literature DB >> 25567179

Response to Lo.

Jong Woo Kim1, Jin Hyoung Kim1.   

Abstract

Mesh：

Year:  2015        PMID： 25567179     DOI： 10.1038/ajg.2014.365

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

2.  A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma.

Authors:  Annie O Chan; Man-Fung Yuen; Chee-Kin Hui; Wai-Kuen Tso; Ching-Lung Lai
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

3.  Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller.

Authors:  Jong Woo Kim; Jin Hyoung Kim; Kyu-Bo Sung; Heung-Kyu Ko; Ji Hoon Shin; Pyo Nyun Kim; Hyun-Kyung Choi; Gi-Young Ko; Hyun-Ki Yoon; Seng-Yong Chun; Dong Il Gwon
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

4.  Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma?

Authors:  Ju Hyun Shim; Joong-Won Park; Joon-Il Choi; Hyun-Beom Kim; Woo Jin Lee; Chang-Min Kim
Journal:  J Vasc Interv Radiol       Date:  2008-12-12       Impact factor: 3.464

5.  Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations.

Authors:  Dong Ik Cha; Min Woo Lee; Hyunchul Rhim; Dongil Choi; Young-sun Kim; Hyo K Lim
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.